legislation: 114-s-3431

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
114-s-3431 114 s 3431 Scleroderma and Fibrosis Research Enhancement Act of 2016 Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Gillibrand, Kirsten E. [D-NY] NY D G000555 2 Scleroderma and Fibrosis Research Enhancement Act of 2016 This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.) The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research. The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness. The commission must be terminated not later than two years after establishment. The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan. 2023-01-11T13:33:31Z  

Links from other tables